Osteoblast and Osteoclast Activity in a Malignant Infantile Osteopetrosis Patient Following Bone Marrow Transplantation

Chun Jung Chen, Tsu Yi Chao, Der Ming Chu, Anthony J. Janckila, Shin Nan Cheng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The authors treated a 6-month-old boy with malignant infantile osteopetrosis using bone marrow transplantation. The patient's clinical response was compared with his biochemical response for bone metabolic markers such as tartrate-resistant acid phosphatase 5b (TRAcP 5b) and bone-specific alkaline phosphatase (BAP). Treatment was successful, resulting in a decrease in the serum TRAcP 5b level. These bone-specific markers may be useful for the early assessment of malignant infantile osteopetrosis patients with stem cell transplantation.

Original languageEnglish
Pages (from-to)5-8
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume26
Issue number1
DOIs
Publication statusPublished - Jan 2004
Externally publishedYes

Fingerprint

Osteopetrosis
Osteoclasts
Osteoblasts
Bone Marrow Transplantation
Bone and Bones
Stem Cell Transplantation
Alkaline Phosphatase
Serum
Tartrate-Resistant Acid Phosphatase
Therapeutics

Keywords

  • Bone marrow transplantation
  • Bone-specific alkaline phosphatase
  • Children
  • Malignant infantile osteopetrosis
  • Tartrate-resistant acid phosphatase 5b

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Osteoblast and Osteoclast Activity in a Malignant Infantile Osteopetrosis Patient Following Bone Marrow Transplantation. / Chen, Chun Jung; Chao, Tsu Yi; Chu, Der Ming; Janckila, Anthony J.; Cheng, Shin Nan.

In: Journal of Pediatric Hematology/Oncology, Vol. 26, No. 1, 01.2004, p. 5-8.

Research output: Contribution to journalArticle

@article{8d857a247e784a358a1bd47f55ad2aec,
title = "Osteoblast and Osteoclast Activity in a Malignant Infantile Osteopetrosis Patient Following Bone Marrow Transplantation",
abstract = "The authors treated a 6-month-old boy with malignant infantile osteopetrosis using bone marrow transplantation. The patient's clinical response was compared with his biochemical response for bone metabolic markers such as tartrate-resistant acid phosphatase 5b (TRAcP 5b) and bone-specific alkaline phosphatase (BAP). Treatment was successful, resulting in a decrease in the serum TRAcP 5b level. These bone-specific markers may be useful for the early assessment of malignant infantile osteopetrosis patients with stem cell transplantation.",
keywords = "Bone marrow transplantation, Bone-specific alkaline phosphatase, Children, Malignant infantile osteopetrosis, Tartrate-resistant acid phosphatase 5b",
author = "Chen, {Chun Jung} and Chao, {Tsu Yi} and Chu, {Der Ming} and Janckila, {Anthony J.} and Cheng, {Shin Nan}",
year = "2004",
month = "1",
doi = "10.1097/00043426-200401000-00003",
language = "English",
volume = "26",
pages = "5--8",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Osteoblast and Osteoclast Activity in a Malignant Infantile Osteopetrosis Patient Following Bone Marrow Transplantation

AU - Chen, Chun Jung

AU - Chao, Tsu Yi

AU - Chu, Der Ming

AU - Janckila, Anthony J.

AU - Cheng, Shin Nan

PY - 2004/1

Y1 - 2004/1

N2 - The authors treated a 6-month-old boy with malignant infantile osteopetrosis using bone marrow transplantation. The patient's clinical response was compared with his biochemical response for bone metabolic markers such as tartrate-resistant acid phosphatase 5b (TRAcP 5b) and bone-specific alkaline phosphatase (BAP). Treatment was successful, resulting in a decrease in the serum TRAcP 5b level. These bone-specific markers may be useful for the early assessment of malignant infantile osteopetrosis patients with stem cell transplantation.

AB - The authors treated a 6-month-old boy with malignant infantile osteopetrosis using bone marrow transplantation. The patient's clinical response was compared with his biochemical response for bone metabolic markers such as tartrate-resistant acid phosphatase 5b (TRAcP 5b) and bone-specific alkaline phosphatase (BAP). Treatment was successful, resulting in a decrease in the serum TRAcP 5b level. These bone-specific markers may be useful for the early assessment of malignant infantile osteopetrosis patients with stem cell transplantation.

KW - Bone marrow transplantation

KW - Bone-specific alkaline phosphatase

KW - Children

KW - Malignant infantile osteopetrosis

KW - Tartrate-resistant acid phosphatase 5b

UR - http://www.scopus.com/inward/record.url?scp=0347634504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347634504&partnerID=8YFLogxK

U2 - 10.1097/00043426-200401000-00003

DO - 10.1097/00043426-200401000-00003

M3 - Article

C2 - 14707702

AN - SCOPUS:0347634504

VL - 26

SP - 5

EP - 8

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -